{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T19:35:13Z","timestamp":1787168113605,"version":"build-2736575974"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2013,7,16]],"date-time":"2013-07-16T00:00:00Z","timestamp":1373932800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Tumor Biol."],"published-print":{"date-parts":[[2013,12]]},"DOI":"10.1007\/s13277-013-0992-8","type":"journal-article","created":{"date-parts":[[2013,7,15]],"date-time":"2013-07-15T11:57:42Z","timestamp":1373889462000},"page":"4017-4026","source":"Crossref","is-referenced-by-count":17,"title":["Expression and significance of miRNA-21 and BTG2 in lung cancer"],"prefix":"10.1007","volume":"34","author":[{"given":"Qing","family":"Sun","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meng","family":"Hang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuedan","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenlong","family":"Shao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guangqiao","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2013,7,16]]},"reference":[{"issue":"2","key":"992_CR1","first-page":"20","volume":"1","author":"K Shimizu","year":"2013","unstructured":"Shimizu K, Okita R, Nakata M. Clinical significance of the tumor microenvironment in non-small cell lung cancer. Ann Transl Med. 2013;1(2):20.","journal-title":"Ann Transl Med"},{"issue":"4","key":"992_CR2","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1007\/s11670-012-0274-9","volume":"24","author":"J Liu","year":"2012","unstructured":"Liu J, Liu X, Cui F, Chen G, Guan Y, He J. The efficacy of the inhalation of an aerosolized Group A streptococcal preparation in the treatment of lung cancer. Chin J Cancer Res. 2012;24(4):346\u201352.","journal-title":"Chin J Cancer Res"},{"issue":"4","key":"992_CR3","first-page":"264","volume":"1","author":"HD Skinner","year":"2012","unstructured":"Skinner HD, Komaki R. Proton radiotherapy in the treatment of lung cancer. Transl Cancer Res. 2012;1(4):264\u201370.","journal-title":"Transl Cancer Res"},{"issue":"2","key":"992_CR4","first-page":"158","volume":"1","author":"C Quintavalle","year":"2012","unstructured":"Quintavalle C, Condorelli G. Dulanermin in cancer therapy: still much to do. Transl Lung Cancer Res. 2012;1(2):158\u20139.","journal-title":"Transl Lung Cancer Res"},{"issue":"5","key":"992_CR5","first-page":"448","volume":"4","author":"A Taenzer","year":"2012","unstructured":"Taenzer A, Alix-Panabi\u00e8res C, Wikman H, Pantel K. Circulating tumor-derived biomarkers in lung cancer. J Thorac Dis. 2012;4(5):448\u20139.","journal-title":"J Thorac Dis"},{"key":"992_CR6","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1007\/978-1-61779-037-9_3","volume":"721","author":"K Plaisance-Bonstaff","year":"2011","unstructured":"Plaisance-Bonstaff K, Renne R. Viral miRNAs. Methods Mol Biol. 2011;721:43\u201366.","journal-title":"Methods Mol Biol"},{"issue":"17","key":"992_CR7","doi-asserted-by":"crossref","first-page":"9779","DOI":"10.1073\/pnas.1630797100","volume":"100","author":"Y Zeng","year":"2003","unstructured":"Zeng Y, Yi R, Cullen BR. MicroRNAs and small interfering RNAs can inhibit mRNA expression by similar mechanisms. Proc Natl Acad Sci U S A. 2003;100(17):9779\u201384.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"4","key":"992_CR8","first-page":"449","volume":"1","author":"HI Pass","year":"2012","unstructured":"Pass HI. Biomarkers and prognostic factors for mesothelioma. Ann Cardiothorac Surg. 2012;1(4):449\u201356.","journal-title":"Ann Cardiothorac Surg"},{"key":"992_CR9","doi-asserted-by":"crossref","unstructured":"Coppola V, Musumeci M, Patrizii M, Cannistraci A, Addario A, Maugeri-Sacca M, et al. BTG2 loss and miR-21 upregulation contribute to prostate cell transformation by inducing luminal markers expression and epithelial-mesenchymal transition. Oncogene 2013;32:1843\u201353","DOI":"10.1038\/onc.2012.194"},{"key":"992_CR10","doi-asserted-by":"crossref","unstructured":"Niu J, Shi Y, Tan G, Yang CH, Fan M, Pfeffer LM, et al. DNA damage induces NF-kappaB-dependent microRNA-21 upregulation and promotes breast cancer cell invasion. J Biol Chem 2012;287:21783\u201395","DOI":"10.1074\/jbc.M112.355495"},{"issue":"4","key":"992_CR11","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.3892\/or.2012.1645","volume":"27","author":"BG Zhang","year":"2012","unstructured":"Zhang BG, Li JF, Yu BQ, Zhu ZG, Liu BY, Yan M. microRNA-21 promotes tumor proliferation and invasion in gastric cancer by targeting PTEN. Oncol Rep. 2012;27(4):1019\u201326.","journal-title":"Oncol Rep"},{"issue":"3\u20134","key":"992_CR12","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1159\/000323283","volume":"79","author":"H Shibuya","year":"2010","unstructured":"Shibuya H, Iinuma H, Shimada R, Horiuchi A, Watanabe T. Clinicopathological and prognostic value of microRNA-21 and microRNA-155 in colorectal cancer. Oncology. 2010;79(3\u20134):313\u201320.","journal-title":"Oncology"},{"issue":"11\u201312","key":"992_CR13","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1016\/j.cca.2010.02.074","volume":"411","author":"JG Zhang","year":"2010","unstructured":"Zhang JG, Wang JJ, Zhao F, Liu Q, Jiang K, Yang GH. MicroRNA-21 (miR-21) represses tumor suppressor PTEN and promotes growth and invasion in non-small cell lung cancer (NSCLC). Clin Chim Acta. 2010;411(11\u201312):846\u201352.","journal-title":"Clin Chim Acta"},{"issue":"4","key":"992_CR14","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1038\/nrg3162","volume":"13","author":"AE Pasquinelli","year":"2012","unstructured":"Pasquinelli AE. MicroRNAs and their targets: recognition, regulation and an emerging reciprocal relationship. Nat Rev Genet. 2012;13(4):271\u201382.","journal-title":"Nat Rev Genet"},{"issue":"5","key":"992_CR15","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.1002\/hep.23547","volume":"51","author":"G Song","year":"2010","unstructured":"Song G, Sharma AD, Roll GR, Ng R, Lee AY, Blelloch RH, et al. MicroRNAs control hepatocyte proliferation during liver regeneration. Hepatology. 2010;51(5):1735\u201343.","journal-title":"Hepatology"},{"issue":"45","key":"992_CR16","doi-asserted-by":"crossref","first-page":"39172","DOI":"10.1074\/jbc.M111.285098","volume":"286","author":"CH Yang","year":"2011","unstructured":"Yang CH, Yue J, Pfeffer SR, Handorf CR, Pfeffer LM. MicroRNA miR-21 regulates the metastatic behavior of B16 melanoma cells. J Biol Chem. 2011;286(45):39172\u20138.","journal-title":"J Biol Chem"},{"issue":"7","key":"992_CR17","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1038\/cr.2009.72","volume":"19","author":"M Liu","year":"2009","unstructured":"Liu M, Wu H, Liu T, Li Y, Wang F, Wan H, et al. Regulation of the cell cycle gene, BTG2, by miR-21 in human laryngeal carcinoma. Cell Res. 2009;19(7):828\u201337.","journal-title":"Cell Res"},{"issue":"4","key":"992_CR18","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1038\/ng1296-482","volume":"14","author":"JP Rouault","year":"1996","unstructured":"Rouault JP, Falette N, Guehenneux F, Guillot C, Rimokh R, Wang Q, et al. Identification of BTG2, an antiproliferative p53-dependent component of the DNA damage cellular response pathway. Nat Genet. 1996;14(4):482\u20136.","journal-title":"Nat Genet"},{"issue":"1","key":"992_CR19","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1002\/jcp.21919","volume":"222","author":"GS Winkler","year":"2010","unstructured":"Winkler GS. The mammalian anti-proliferative BTG\/Tob protein family. J Cell Physiol. 2010;222(1):66\u201372.","journal-title":"J Cell Physiol"},{"issue":"7\u20138","key":"992_CR20","first-page":"E242","volume":"91","author":"C Duriez","year":"2004","unstructured":"Duriez C, Moyret-Lalle C, Falette N, El-Ghissassi F, Puisieux A. BTG2, its family and its tutor. Bull Cancer. 2004;91(7\u20138):E242\u201353.","journal-title":"Bull Cancer"},{"issue":"7","key":"992_CR21","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1007\/s00432-006-0080-1","volume":"132","author":"IK Lim","year":"2006","unstructured":"Lim IK. TIS21 (\/BTG2\/PC3) as a link between ageing and cancer: cell cycle regulator and endogenous cell death molecule. J Cancer Res Clin Oncol. 2006;132(7):417\u201326.","journal-title":"J Cancer Res Clin Oncol"},{"issue":"1","key":"992_CR22","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1007\/s12013-011-9164-x","volume":"61","author":"Z Zhang","year":"2011","unstructured":"Zhang Z, Chen C, Wang G, Yang Z, San J, Zheng J, et al. Aberrant expression of the p53-inducible antiproliferative gene BTG2 in hepatocellular carcinoma is associated with overexpression of the cell cycle-related proteins. Cell Biochem Biophys. 2011;61(1):83\u201391.","journal-title":"Cell Biochem Biophys"},{"issue":"13","key":"992_CR23","doi-asserted-by":"crossref","first-page":"4222","DOI":"10.1093\/nar\/gkn394","volume":"36","author":"E Horvilleur","year":"2008","unstructured":"Horvilleur E, Bauer M, Goldschneider D, Mergui X, de la Motte A, Benard J, et al. p73alpha isoforms drive opposite transcriptional and post-transcriptional regulation of MYCN expression in neuroblastoma cells. Nucleic Acids Res. 2008;36(13):4222\u201332.","journal-title":"Nucleic Acids Res"},{"issue":"2","key":"992_CR24","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1101\/gad.1372606","volume":"20","author":"AD Boiko","year":"2006","unstructured":"Boiko AD, Porteous S, Razorenova OV, Krivokrysenko VI, Williams BR, Gudkov AV. A systematic search for downstream mediators of tumor suppressor function of p53 reveals a major role of BTG2 in suppression of Ras-induced transformation. Genes Dev. 2006;20(2):236\u201352.","journal-title":"Genes Dev"},{"issue":"2","key":"992_CR25","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1002\/jcp.1062","volume":"187","author":"F Tirone","year":"2001","unstructured":"Tirone F. The gene PC3(TIS21\/BTG2), prototype member of the PC3\/BTG\/TOB family: regulator in control of cell growth, differentiation, and DNA repair? J Cell Physiol. 2001;187(2):155\u201365.","journal-title":"J Cell Physiol"},{"issue":"27","key":"992_CR26","doi-asserted-by":"crossref","first-page":"3084","DOI":"10.1038\/onc.2011.24","volume":"30","author":"F Takahashi","year":"2011","unstructured":"Takahashi F, Chiba N, Tajima K, Hayashida T, Shimada T, Takahashi M, et al. Breast tumor progression induced by loss of BTG2 expression is inhibited by targeted therapy with the ErbB\/HER inhibitor lapatinib. Oncogene. 2011;30(27):3084\u201395.","journal-title":"Oncogene"},{"issue":"6","key":"992_CR27","doi-asserted-by":"crossref","first-page":"2579","DOI":"10.1007\/s11033-009-9777-y","volume":"37","author":"L Zhang","year":"2010","unstructured":"Zhang L, Huang H, Wu K, Wang M, Wu B. Impact of BTG2 expression on proliferation and invasion of gastric cancer cells in vitro. Mol Biol Rep. 2010;37(6):2579\u201386.","journal-title":"Mol Biol Rep"},{"key":"992_CR28","doi-asserted-by":"crossref","unstructured":"Wei S, Hao C, Li X, Zhao H, Chen J, and Zhou Q. Effects of BTG2 on proliferation inhibition and anti-invasion in human lung cancer cells. Tumour Biol 2012;33:1223\u201330","DOI":"10.1007\/s13277-012-0370-y"},{"issue":"3","key":"992_CR29","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/j.cell.2012.04.005","volume":"149","author":"MS Ebert","year":"2012","unstructured":"Ebert MS, Sharp PA. Roles for microRNAs in conferring robustness to biological processes. Cell. 2012;149(3):515\u201324.","journal-title":"Cell"},{"issue":"7","key":"992_CR30","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1093\/jnci\/djs027","volume":"104","author":"VS Nair","year":"2012","unstructured":"Nair VS, Maeda LS, Ioannidis JP. Clinical outcome prediction by microRNAs in human cancer: a systematic review. J Natl Cancer Inst. 2012;104(7):528\u201340.","journal-title":"J Natl Cancer Inst"},{"issue":"6","key":"992_CR31","doi-asserted-by":"crossref","first-page":"472","DOI":"10.3945\/an.111.001206","volume":"2","author":"SA Ross","year":"2011","unstructured":"Ross SA, Davis CD. MicroRNA, nutrition, and cancer prevention. Adv Nutr. 2011;2(6):472\u201385.","journal-title":"Adv Nutr"},{"issue":"5543","key":"992_CR32","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1126\/science.1064921","volume":"294","author":"M Lagos-Quintana","year":"2001","unstructured":"Lagos-Quintana M, Rauhut R, Lendeckel W, Tuschl T. Identification of novel genes coding for small expressed RNAs. Science. 2001;294(5543):853\u20138.","journal-title":"Science"},{"key":"992_CR33","doi-asserted-by":"crossref","unstructured":"Ribas J, Ni X, Castanares M, Liu MM, Esopi D, Yegnasubramanian S, et al. A novel source for miR-21 expression through the alternative polyadenylation of VMP1 gene transcripts. Nucleic Acids Res 2012;40:6821\u201333","DOI":"10.1093\/nar\/gks308"},{"issue":"3","key":"992_CR34","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1016\/j.jmb.2008.03.015","volume":"378","author":"S Fujita","year":"2008","unstructured":"Fujita S, Ito T, Mizutani T, Minoguchi S, Yamamichi N, Sakurai K, et al. miR-21 gene expression triggered by AP-1 is sustained through a double-negative feedback mechanism. J Mol Biol. 2008;378(3):492\u2013504.","journal-title":"J Mol Biol"},{"issue":"1","key":"992_CR35","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/1471-2490-12-14","volume":"12","author":"ST Reis","year":"2012","unstructured":"Reis ST, Pontes-Junior J, Antunesnes AA, Dall Oglio MF, Dip N, Passerotti CC, et al. miR-21 may acts as an oncomir by targeting RECK, a matrix metalloproteinase regulator, in prostate cancer. BMC Urol. 2012;12(1):14.","journal-title":"BMC Urol"},{"issue":"1","key":"992_CR36","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1038\/modpathol.2011.142","volume":"25","author":"Y Nagao","year":"2012","unstructured":"Nagao Y, Hisaoka M, Matsuyama A, Kanemitsu S, Hamada T, Fukuyama T, et al. Association of microRNA-21 expression with its targets, PDCD4 and TIMP3, in pancreatic ductal adenocarcinoma. Mod Pathol. 2012;25(1):112\u201321.","journal-title":"Mod Pathol"},{"issue":"26","key":"992_CR37","doi-asserted-by":"crossref","first-page":"20281","DOI":"10.1074\/jbc.M110.109207","volume":"285","author":"D Sayed","year":"2010","unstructured":"Sayed D, He M, Hong C, Gao S, Rane S, Yang Z, et al. MicroRNA-21 is a downstream effector of AKT that mediates its antiapoptotic effects via suppression of Fas ligand. J Biol Chem. 2010;285(26):20281\u201390.","journal-title":"J Biol Chem"},{"key":"992_CR38","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.brainres.2009.06.053","volume":"1286","author":"Y Li","year":"2009","unstructured":"Li Y, Li W, Yang Y, Lu Y, He C, Hu G, et al. MicroRNA-21 targets LRRFIP1 and contributes to VM-26 resistance in glioblastoma multiforme. Brain Res. 2009;1286:13\u20138.","journal-title":"Brain Res"},{"issue":"19","key":"992_CR39","doi-asserted-by":"crossref","first-page":"8164","DOI":"10.1158\/0008-5472.CAN-08-1305","volume":"68","author":"T Papagiannakopoulos","year":"2008","unstructured":"Papagiannakopoulos T, Shapiro A, Kosik KS. MicroRNA-21 targets a network of key tumor-suppressive pathways in glioblastoma cells. Cancer Res. 2008;68(19):8164\u201372.","journal-title":"Cancer Res"},{"issue":"21","key":"992_CR40","doi-asserted-by":"crossref","first-page":"2433","DOI":"10.1038\/onc.2010.620","volume":"30","author":"HJ Kwak","year":"2011","unstructured":"Kwak HJ, Kim YJ, Chun KR, Woo YM, Park SJ, Jeong JA, et al. Downregulation of Spry2 by miR-21 triggers malignancy in human gliomas. Oncogene. 2011;30(21):2433\u201342.","journal-title":"Oncogene"},{"issue":"32","key":"992_CR41","doi-asserted-by":"crossref","first-page":"9779","DOI":"10.1021\/bi034731y","volume":"42","author":"A Meyer","year":"2003","unstructured":"Meyer A, Cirpus P, Ott C, Schlecker R, Zahringer U, Heinz E. Biosynthesis of docosahexaenoic acid in Euglena gracilis: biochemical and molecular evidence for the involvement of a Delta4-fatty acyl group desaturase. Biochemistry. 2003;42(32):9779\u201388.","journal-title":"Biochemistry"},{"issue":"20","key":"992_CR42","doi-asserted-by":"crossref","first-page":"7392","DOI":"10.1158\/1078-0432.CCR-05-0283","volume":"11","author":"S Hagan","year":"2005","unstructured":"Hagan S, Al-Mulla F, Mallon E, Oien K, Ferrier R, Gusterson B, et al. Reduction of Raf-1 kinase inhibitor protein expression correlates with breast cancer metastasis. Clin Cancer Res. 2005;11(20):7392\u20137.","journal-title":"Clin Cancer Res"},{"issue":"14","key":"992_CR43","doi-asserted-by":"crossref","first-page":"7075","DOI":"10.1158\/0008-5472.CAN-06-0379","volume":"66","author":"H Kawakubo","year":"2006","unstructured":"Kawakubo H, Brachtel E, Hayashida T, Yeo G, Kish J, Muzikansky A, et al. Loss of B-cell translocation gene-2 in estrogen receptor-positive breast carcinoma is associated with tumor grade and overexpression of cyclin d1 protein. Cancer Res. 2006;66(14):7075\u201382.","journal-title":"Cancer Res"},{"key":"992_CR44","doi-asserted-by":"crossref","unstructured":"Lim SK, Choi YW, Lim IK, and Park TJ. BTG2 suppresses cancer cell migration through inhibition of Src-FAK signaling by downregulation of reactive oxygen species generation in mitochondria. Clin Exp Metastasis 2012; 29:901\u201313","DOI":"10.1007\/s10585-012-9479-z"}],"updated-by":[{"DOI":"10.1007\/s13277-014-1973-2","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2014,6,7]],"date-time":"2014-06-07T00:00:00Z","timestamp":1402099200000}}],"container-title":["Tumor Biology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13277-013-0992-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s13277-013-0992-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13277-013-0992-8","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,7,18]],"date-time":"2019-07-18T04:02:11Z","timestamp":1563422531000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s13277-013-0992-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,7,16]]},"references-count":44,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2013,12]]}},"alternative-id":["992"],"URL":"https:\/\/doi.org\/10.1007\/s13277-013-0992-8","relation":{},"ISSN":["1010-4283","1423-0380"],"issn-type":[{"value":"1010-4283","type":"print"},{"value":"1423-0380","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,7,16]]}}}